This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SUMMARY: One of the biggest complaints people have about their health is the lack of sleep caused by many factors, from diet and weight to chronic stress. DTC for a product that can keep people awake for nine hours is a message for potential abuse. Did I mention that they are using a flying pig in their DTC? One of the most common complaints people have is “lack of energy” Consumers have turned to energy drinks which was valued at $53.01 billion in 2018, and is expected to grow at a
3D medical animation is how the new wave of medical marketing will render. There are a couple of reasons 3D medical animation is a great way to market to the medical industry. Most prevalently is that advances in technology are driving medical marketing’s reliance on 3d animation. These trends aren’t just reflecting in the marketing world either.
Reading time: 3 – 5 minutes Does your operations team collaborate with sales and marketing to create a virtuous circle that is a win for the customer, the employees and sales revenue? Learn how Jeff does it. Jeff started his career in sales and made his way into MedTech operational leadership. As COO at Endologix, he and his team won the Turnaround of the Year Award from the Association for Corporate Growth.
Welcome to the calm before the Covid-19 storm. The medtechs that enjoy the highest sales for their headcount tend to be those making large, expensive machines or largely genericized orthopedic implants – the types of product that tend to require relatively little in the way of R&D expenditure. But these devices are heavily used in elective procedures, and this is exactly where demand has cratered so far this year thanks to the pandemic.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
SUMMARY: Per the Times, “what if consumers could calculate the benefits and risks of taking a prescription drug as easily as they can gauge the carbohydrates and calories in an Oreo cookie?” Drug facts boxes are needed, but the FDA disagrees. According to the AMA one of the key reasons for non-adherence is that patients may be frightened of potential side effects.
Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and pressure is there to found a new era of agile, patient-centric clinical trials. Long-standing barriers to innovation are falling, digital transformation is accelerating, and new cultures in collaboration, and patient-centricity are rapidly growing. The conversations that are re-shaping the future of clinical are happening as we speak, Reuters Events Clinical 2021 is the new meeting place for US and EU
Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and pressure is there to found a new era of agile, patient-centric clinical trials. Long-standing barriers to innovation are falling, digital transformation is accelerating, and new cultures in collaboration, and patient-centricity are rapidly growing. The conversations that are re-shaping the future of clinical are happening as we speak, Reuters Events Clinical 2021 is the new meeting place for US and EU
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resources. This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25th February 13:00 GMT / 14:00 CET and discuss the UK’s approach to delivering research during the COVID-19 pandemic.
2020 has affected every aspect of our lives, from how we work to how we spend our free time. As industries scrambled to keep going during the global pandemic, it highlighted the need for virtual accessibility. The impact of the Covid-19 pandemic is not temporary but a complete change in the landscape of healthcare marketing. . Changes in consumer search behavior and PPC performance, along with new competitors and market share, can make marketing your practice challenging.
As markets swell with digital content and HCPs become increasingly time-poor, your customer engagement strategy can no longer be driven by reach and frequency, but by the value added at every interaction and touchpoint. At Pharma Customer Engagement Europe (20-22 April, Virtual) leaders unite to develop hybrid field force models, measure true digital effectiveness, and optimize content to make holistic customer engagement the norm and surpass HCP needs.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
I t is probably reasonable enough by now to talk about the launch readiness landscape for medicines and vaccines as pre- and post-COVID. We can also say with some certainty that nothing will ever be the same again.
If a sales organization creates a great incentive compensation plan, but the sales team fails to execute it efficiently, is it still great? Companies often go through an entire process.
SUMMARY: In a recent study by The Harris Poll on behalf of TIME, the overwhelming majority of Americans (78%) admitted to delaying routine medical services and health care appointments due to the coronavirus pandemic. The health care industry should invest more in patient outreach, communication and education. Via The NY Times “the coronavirus pandemic has yet to end, but we are already beginning to feel the aftershocks.
Look around – what do you see? Empowered patients, remote monitoring and care, platform technologies, personalized and preventative health, AI, machine learning and advanced analytics, virtual engagement, decentralized trials, telehealth, cell and gene therapy commercialization… the list goes on. Pharma is undergoing a period of unrivaled change.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
SUMMARY: Pharma’s reputation got a bump the latest Harris Poll survey shows but behind the numbers is more of a reality. Overall, about 16% of Americans had a negative or more negative view of pharma in mid-May, which was again on par with April sentiment. The only reason given by a majority (53%) was the criticism that pharma is not making drug treatments more affordable during this time of crisis.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
181 
Let's personalize your content